No CrossRef data available.
Article contents
Neuroleptic Malignant Syndrome (NMS) and Tardive Dyskinesia
Published online by Cambridge University Press: 02 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0007125000215067/resource/name/firstPage-S0007125000215067a.jpg)
- Type
- Correspondence
- Information
- Copyright
- Copyright © 1987 The Royal College of Psychiatrists
References
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google ScholarPubMed
Corlon, P. (1986) The spectrum concept of neuroleptic toxicity. American Journal of Psychiatry, 143, 811.Google Scholar
Shalev, A. & Munitz, H. (1986) The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrica Scandinavica. 73, 337–347.CrossRefGoogle ScholarPubMed
Sternberg, D. E. (1986) Neuroleptic malignant syndrome: the pendulum swings. American Journal of Psychiatry, 143, 1273–1275.Google ScholarPubMed
Woo, J., Tech, R. & Vallence-Owen, J. (1986) Neuroleptic malignant syndrome successfully treated with amantidine. Postgraduate Medical Journal, 62, 809–810.CrossRefGoogle ScholarPubMed
eLetters
No eLetters have been published for this article.